Gene and protein expression markers of response to combined antiangiogenic and epidermal growth factor targeted therapy in renal cell carcinoma

Background: Metastatic renal cell carcinoma (mRCC) patients treated with anti-vascular endothelial growth factor (VEGF) therapies demonstrate promising outcomes but not all patients benefit. Factors that predict response remain to be elucidated. Patients and methods: Nephrectomy material from 37 pat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Tsavachidou-Fenner, D., Tannir, N., Tamboli, P., Liu, W., Petillo, D., Teh, B., Mills, G. B., Jonasch, E.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2010
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4092253/
https://ncbi.nlm.nih.gov/pubmed/20089566
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdp600
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados